Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors.
Saved in:
| Title: | Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors. |
|---|---|
| Authors: | Yang Y; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA.; VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Mandt T; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA., Mittelstein D; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA., Das M; VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Wu P; VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Ghani MA; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA., Illindala R; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA.; School of Medicine, University of California San Diego, La Jolla, CA, USA., Steinmetz NF; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California San Diego, La Jolla, CA, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Center for Nano-ImmunoEngineering, University of California San Diego, La Jolla, CA, USA.; Center for Engineering in Cancer, Institute for Engineering in Medicine, University of California San Diego, La Jolla, CA, USA.; Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, CA, USA.; Institute for Materials Discovery and Design, University of California San Diego, La Jolla, CA, USA., Burgoyne AM; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.; Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA, USA., Berman Z; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA., Webster N; Department of Medicine, University of California San Diego, La Jolla, CA, USA.; Research Service, Jennifer Moreno VA Medical Center, San Diego, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Newton IG; Department of Radiology, Division of Interventional Radiology, University of California San Diego, San Diego, CA, USA. inewton@ucsd.edu.; VA San Diego Healthcare System, 3350 La Jolla Village Drive, San Diego, CA, 92161, USA. inewton@ucsd.edu.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA. inewton@ucsd.edu. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Feb 12; Vol. 75 (3), pp. 74. Date of Electronic Publication: 2026 Feb 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-025-04286-8 |
